OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 13 citing articles:

Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis
Cataldo Patruno, Luca Potestio, Gabriella Fabbrocini, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 12
Closed Access | Times Cited: 20

Atopic Dermatitis: Clinical Aspects and Unmet Needs
Fabio Lobefaro, Giulio Gualdi, Sergio Di Nuzzo, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2927-2927
Open Access | Times Cited: 16

Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis
Yael Renert‐Yuval, Ester Del Duca, B.W.M. Arents, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 1, pp. 42-51
Open Access | Times Cited: 6

Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience
Luigi Gargiulo, Francesco Piscazzi, Luciano Ibba, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 4

The sound of silence: where are the voices of patients in eczema guideline development?
Korey Capozza, Anne Vastrup, Andrew Proctor, et al.
British Journal of Dermatology (2022) Vol. 187, Iss. 6, pp. 1005-1006
Open Access | Times Cited: 5

Cost-effectiveness analysis of baricitinib versus dupilumab for moderate to severe atopic dermatitis: an Italian healthcare system perspective
Erin Johansson, Massimo Giovannitti, Maurizio Mezzetti, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 1155-1166
Open Access | Times Cited: 2

Cutaneous Diseases Precipitated or Perpetuated by Emotional Factors
Luca Stingeni, Katharina Hansel, E. Cecchini
(2024), pp. 157-175
Closed Access

Association between type 2 inflammatory diseases and neurodevelopmental disorders in low-birth-weight children and adolescents
Hengye Huang, Kelvin Pengyuan Zhang, Karol Kexin Sun, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access

Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment
Giulia Ronconi, Letizia Dondi, Silvia Calabria, et al.
Italian Journal of Dermatology and Venereology (2024) Vol. 159, Iss. 4
Closed Access

AtopyReg®: the prospective Italian patient registry for moderate to severe atopic dermatitis in adults by SIDeMaST
Gabriella Fabbrocini, Katharina Hansel, Monica Corazza, et al.
Italian Journal of Dermatology and Venereology (2023) Vol. 158, Iss. 2
Open Access | Times Cited: 1

Real-Life Safety and Effectiveness of Dupilumab in Patients With Concomitant Malignancies: A Case Series
Luigi Gargiulo, Carlo Alberto Vignoli, Andrea Cortese, et al.
Dermatology Practical & Conceptual (2023), pp. e2023143-e2023143
Open Access | Times Cited: 1

Algoritmo de tratamiento de la dermatitis atópica en Perú. Consenso de expertos
Pablo Butron, César Galván-Calle, Rosalía Ballona, et al.
Deleted Journal (2023) Vol. 70, Iss. 3, pp. 167-186
Open Access

AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History
Luca Stingeni, Andrea Chiricozzi, Piergiacomo Calzavara‐Pinton, et al.
American Journal of Clinical Dermatology (2023) Vol. 25, Iss. 1, pp. 149-160
Open Access

Page 1

Scroll to top